Comparative Analysis of Different Approaches to Measure Treatment Response in Acute Myeloid Leukemia | Zendy

Hiroto Inaba | Zendy; Elaine CoustanSmith | Zendy; Xueyuan Cao | Zendy; Stanley Pounds | Zendy; Sheila Shurtleff | Zendy; Kathleen Y. Wang | Zendy; Susana C. Raimondi | Zendy; Mihaela Onciu | Zendy; Jeffrey Jacobsen | Zendy; Raul C. Ribeiro | Zendy; Gary V. Dahl | Zendy; W. Paul Bowman | Zendy; Jeffrey W. Taub | Zendy; Barbara Degar | Zendy; Wing Leung | Zendy; James R. Downing | Zendy; ChingHon Pui | Zendy; Jeffrey E. Rubnitz | Zendy; Dario Campana | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Comparative Analysis of Different Approaches to Measure Treatment Response in Acute Myeloid Leukemia

Author(s) -

Hiroto Inaba,

Elaine CoustanSmith,

Xueyuan Cao,

Stanley Pounds,

Sheila Shurtleff,

Kathleen Y. Wang,

Susana C. Raimondi,

Mihaela Onciu,

Jeffrey Jacobsen,

Raul C. Ribeiro,

Gary V. Dahl,

W. Paul Bowman,

Jeffrey W. Taub,

Barbara Degar,

Wing Leung,

James R. Downing,

ChingHon Pui,

Jeffrey E. Rubnitz,

Dario Campana

Publication year - 2012

Publication title -

journal of clinical oncology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 10.482

H-Index - 548

eISSN - 1527-7755

pISSN - 0732-183X

DOI - 10.1200/jco.2011.41.5323

Subject(s) - flow cytometry , minimal residual disease , medicine , myeloid leukemia , bone marrow , leukemia , cytometry , myeloid , acute leukemia , oncology , pathology , immunology

In acute myeloid leukemia (AML), initial treatment response by morphologic analysis of bone marrow predicts long-term outcome. Response can now be assessed by minimal residual disease (MRD) monitoring with flow cytometry or polymerase chain reaction (PCR). We determined the relation among the results of these approaches and their prognostic value.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research